Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration
Launched by CHILDREN'S HOSPITAL MEDICAL CENTER, CINCINNATI · Dec 6, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a retrospective and prospective, multicenter observational quality improvement study and research registry. Infants undergoing renal replacement therapy utilizing CARPEDIEM for hemodialysis will be enrolled in the study for observation. There are two arms to this study, one for quality improvement and one for research purposes. Patients enrolled in this study have the option to participate additionally in either biospecimen collection, long term follow up after CARPEDIEM, or both. Urine specimen will be collected from fresh voids, but all blood specimen will be obtained from residua...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Treated with CARPEDIEM as part of standard of care at a participating institution within the United States
- Exclusion Criteria:
- • Parents/legally authorized representative unable or unwilling to provide consent
About Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center in Cincinnati is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and comprehensive patient care. Renowned for its commitment to excellence, the center conducts a wide range of clinical trials aimed at developing and evaluating new treatments and therapies for pediatric populations. With a focus on multidisciplinary collaboration and ethical research practices, Children's Hospital Medical Center strives to improve health outcomes for children while contributing to the broader scientific understanding of pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Houston, Texas, United States
Omaha, Nebraska, United States
Aurora, Colorado, United States
Milwaukee, Wisconsin, United States
Seattle, Washington, United States
Palo Alto, California, United States
Atlanta, Georgia, United States
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Cara Slagle, MD
Principal Investigator
Cincinnati Children's
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials